The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Releasing the brakes: the role of immune checkpoint inhibitors in laryngeal cancer”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Piotr Kawczak, Igor Jarosław Feszak, Tomasz Bączek. Comparative Mechanistic Insights and Therapeutic Potential of Pembrolizumab, Durvalumab, and Ipilimumab as Immune Checkpoint Inhibitors in the Targeted Management of Oral and Head and Neck Squamous Cell Carcinoma, Cancers. 2025; 17: 2805. https://doi.org/10.3390/cancers17172805 |
|
2 |
2025 |
Aurelius Scheer, Lars Bräuer, Markus Eckstein, Heinrich Iro, Friedrich Paulsen, Fabian Garreis, Martin Schicht, Antoniu-Oreste Gostian. The Potential Role of SP-G and PLUNC in Tumor Pathogenesis and Wound Healing in the Human Larynx, Biomedicines. 2025; 13: 1240. https://doi.org/10.3390/biomedicines13051240 |
|
3 |
2026 |
Andrés Coca-Pelaz, Primoz Strojan, Nina Zidar, Juan P. Rodrigo, Abbas Agaimy, Göran Stenman, Orlando Guntinas-Lichius, Roderick HW Simpson, Alfons Nadal, Alfio Ferlito. “Histologic type, treatment and prognosis of carcinomas of the larynx: A review”, Virchows Archiv. 2026; https://doi.org/10.1007/s00428-026-04643-7 |